Casandra
Casandra Test Code QD99194Version 1 (DRAFT)
Performing Lab
Drug Monitoring, Benzodiazepines, Quantitative, Urine
Also known as: Pain Management, Prescription Drug Monitoring
Clinical Use
Order TestUse
Quantitative measurement of benzodiazepines and their metabolites in urine, intended for monitoring therapeutic drug use or detecting benzodiazepine exposure levels. This assay provides detailed concentration values for multiple benzodiazepine analytes to support clinical interpretation of patient drug use patterns.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
9 targets
AlphahydroxyalprazolamAlphahydroxymidazolamAlphahydroxytriazolamAminoclonazepamHydroxyethylflurazepamLorazepamNordiazepamOxazepam+1 more
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
10 mL (9 mL minimum)
Minimum Volume
9 mL
Container
plastic urine container
Causes for Rejection
Preserved urine
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |
Related Tests
Other tests from different labs that may be relevant
Benzodiazepines, Urine, Quantitative
ARUP Laboratories
Benzodiazepines, Urine Screen with Reflex to Quantitation
ARUP Laboratories
Benzodiazepine Confirmation, Urine
Mayo Clinic Lab
Targeted Benzodiazepine Screen, Random, Urine
Mayo Clinic Lab
Benzodiazepines Confirmation, Random, Urine
Mayo Clinic Lab
Benzodiazepines Confirmation, Chain of Custody, Random, Urine
Mayo Clinic Lab
Lorazepam Confirmation, Quantitative, Urine
Labcorp
Designer Benzodiazepines, Screen With Confirmation, Urine Clinical
Labcorp
Benzodiazepines, Screen Only, Urine
Labcorp